Standard Biotools (LAB) Other financing activities (2011 - 2026)

Standard Biotools (LAB) has 16 years of Other financing activities data on file, last reported at $78000.0 in Q1 2026.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $78000.0 in Q1 2026; TTM through Mar 2026 was $601000.0, a 44.35% decrease from a year earlier, with the FY2025 full-year figure at $523000.0, down 54.6% from the prior year.
• Other financing activities for Q1 2026 stood at $78000.0, down from $523000.0 in the prior quarter.
• Over the last five years, Other financing activities for LAB reached as high as $980000.0 in Q2 2024 and fell as low as -$400000.0 in Q3 2022.
• Historically, Other financing activities has averaged $218750.0 across 5 years, with a median of $75000.0 in 2024.
• Across the five-year window, Other financing activities plunged 158.39% in 2022 and surged 1534.38% in 2025, its largest moves.
• Year by year, Other financing activities stood at -$400000.0 in 2022, then surged by 199.25% to $397000.0 in 2023, then sank by 91.94% to $32000.0 in 2024, then jumped by 1534.38% to $523000.0 in 2025, then tumbled by 85.09% to $78000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $78000.0 in Q1 2026, $523000.0 in Q4 2025, and $32000.0 in Q4 2024.